FKBP10 promotes proliferation of glioma cells via activating AKT-CREB-PCNA axis
Open Access
- 9 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Biomedical Science
- Vol. 28 (1), 1-15
- https://doi.org/10.1186/s12929-020-00705-3
Abstract
Background: Although the availability of therapeutic options including temozolomide, radiotherapy and some target agents following neurosurgery, the prognosis of glioma patients remains poor. Thus, there is an urgent need to explore possible targets for clinical treatment of this disease. Methods: Tissue microarrays and immunohistochemistry were used to detect FKBP10, Hsp47, p-AKT (Ser473), p-CREB (Ser133) and PCNA expression in glioma tissues and xenografts. CCK-8 tests, colony formation assays and xenograft model were performed to test proliferation ability of FKBP10 in glioma cells in vitro and in vivo. Quantitative reverse transcriptase-PCR, western-blotting, GST-pull down, co-immunoprecipitation and confocal-immunofluorescence staining assay were used to explore the molecular mechanism underlying the functions of overexpressed FKBP10 in glioma cells. Results: FKBP10 was highly expressed in glioma tissues and its expression was positively correlates with grade, poor prognosis. FKBP10-knockdown suppressed glioma cell proliferation in vitro and subcutaneous/orthotopic xenograft tumor growth in vivo. Silencing of FKBP10 reduced p-AKT (Ser473), p-CREB (Ser133), PCNA mRNA and PCNA protein expression in glioma cells. FKBP10 interacting with Hsp47 enhanced the proliferation ability of glioma cells via AKT-CREB-PCNA cascade. In addition, correlation between these molecules were also found in xenograft tumor and glioma tissues. Conclusions: We showed for the first time that FKBP10 is overexpressed in glioma and involved in proliferation of glioma cells by interacting with Hsp47 and activating AKT-CREB-PCNA signaling pathways. Our findings suggest that inhibition of FKBP10 related signaling might offer a potential therapeutic option for glioma patients.Keywords
Funding Information
- Postdoctoral Research Foundation of China (2019M650570)
- CAMS Innovation Fund for Medical Sciences (2017-I2M-1-005, 2016-I2M-1-001, 2019-I2M-1-003)
This publication has 33 references indexed in Scilit:
- FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2015
- p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendrogliomaHuman Pathology, 2015
- Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung TumorigenesisCell Metabolism, 2015
- HSP47 and FKBP65 cooperate in the synthesis of type I procollagenHuman Molecular Genetics, 2014
- Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferationOncogenesis, 2014
- FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcomeInternational Journal of Oncology, 2013
- Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Mutations in FKBP10 cause recessive osteogenesis imperfecta and bruck syndromeJournal of Bone and Mineral Research, 2010
- Human FK506 Binding Protein 65 Is Associated with Colorectal CancerMolecular & Cellular Proteomics, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005